Biostax Corp (BTAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30 | 151 | 494 | 10 | 5 |
| Marketable Securities | N/A | N/A | 2,645 | N/A | N/A |
| TOTAL | $30 | $151 | $3,139 | $10 | $5 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 1 |
| Intangibles | 0 | 763 | 0 | 0 | 0 |
| Other Non-Current Assets | 6 | 51 | 0 | 0 | 0 |
| TOTAL | $6 | $813 | $N/A | $0 | $1 |
| Total Assets | $35 | $964 | $3,139 | $10 | $6 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,509 | 1,850 | 2,185 | 2,563 | 2,656 |
| Accrued Expenses | 761 | 537 | 4,225 | 4,484 | 4,647 |
| Other current liabilities | 1,163 | 395 | 1,607 | 1,786 | 846 |
| TOTAL | $4,563 | $3,477 | $11,087 | $11,677 | $13,694 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,563 | $3,477 | $11,087 | $11,677 | $13,694 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,739 | 83,296 | 484 | 0 | 0 |
| Common Shares | 8 | 8 | 0 | 0 | 0 |
| Retained earnings | -385,331 | -382,969 | -379,432 | -383,019 | -384,607 |
| Other shareholders' equity | 0 | 10 | 10 | 10 | 10 |
| TOTAL | $-4,528 | $-2,514 | $-7,948 | $-11,667 | $-13,689 |
| Total Liabilities And Equity | $35 | $964 | $3,139 | $10 | $6 |